Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels | ||
---|---|---|---|---|---|
1 | 2 | 3 | |||
Nasopharyngitis | uncommon, 7.01% | 6.07% | x | x | |
Diarrhoea | 3.28% | 2.99% | x | ||
Cough | uncommon, 2.1% | 1.38% | x | x | |
Constipation | uncommon | x | x | ||
Pancreatitis acute | postmarketing | x | |||
Anaphylactic shock | postmarketing | x | |||
Angioedema | postmarketing | x | x | ||
Rash | postmarketing | x | x | ||
Hypersensitivity | postmarketing | x | x | ||
Immune system disorder | postmarketing | x | |||
Pancreatitis | postmarketing, uncommon | x | x | x | |
Skin disorder | postmarketing | x | |||
Urticaria | postmarketing | x | x | ||
Unspecified disorder of skin and subcutaneous tissue | postmarketing | x | |||
Arthralgia | x | x | |||
Back pain | x | x | |||
Infection | x | ||||
Gastrointestinal disorder | x | ||||
Headache | x | x | |||
Hyperlipidaemia | x | ||||
Hypertriglyceridaemia | x | x | |||
Hypoglycaemia | x | x | x | ||
Mediastinal disorder | x | ||||
Pain in extremity | x | ||||
Upper respiratory tract infection | x | ||||
Urinary tract infection | x | x | |||
Weight increased | x | ||||
Bronchial hyperreactivity | x | x | |||
Malnutrition | x | ||||
Myalgia | x | x | |||
Skin exfoliation | x | x | |||
Diabetic | x | ||||
Hypoglycemic reaction | x | ||||
Infestation NOS | x | ||||
Blood triglycerides increased | x |
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |